High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment
Parisi E, Romeo A, Sarnelli A, Ghigi G, Bellia SR, Neri E, Micheletti S, Dipalma B, Arpa D, Furini G, Burgio MA, Genestreti G, Gurioli C, Sanna S, Bovolato P, Rea F, Storme G, Scarpi E, Arienti C, Tesei A, Polico R | Cancer Radiother | 2017
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis
Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M, Simontacchi G, Viggiano D, Lanfranchi B, Gonfiotti A, Topulli J, Olmetto E, Maragna V, Ferrari K, Bonti V, Comin C, Balduzzi S, D’Amico R, Lohr F, Voltolini L, Livi L | Clin Lung Cancer | 2019
A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report
Okada W, Doi H, Tanooka M, Sano K, Nakamura K, Sakai Y, Shibata M, Tanaka M | SAGE Open Med Case Rep | 2021
Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection
Baumann BC, Nagda SN, Kolker JD, Levin WP, Weber KL, Berman AT, Staddon A, Hartner L, Hahn SM, Glatstein E, Simone CB | J Surg Oncol. | 2016
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Lischalk JW, Malik RM, Collins SP, Collins BT, Matus IA, Anderson ED | Radiat Oncol. | 2016
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT | Radiat Oncol. | 2017
Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy
Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. | Acta Oncol | 2018
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
Sumodhee S, Bondiau PY, Poudenx M, Cohen C, Naghavi AO, Padovani B, Maneval D, Gal J, Leysalle A, Ghalloussi H, Otto J, Doyen J | BMC Cancer | 2019
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer
Abe T, Ryuno Y, Iino M, Saito S, Aoshika T, Ohta T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Jpn J Clin Oncol. | 2021
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches
Alessio Casutt, Rémy Kinj, Esat-Mahmut Ozsahin, Christophe von Garnier, Alban Lovis | Eur Respir Rev | 2022
Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis
Severin Rodler, Melanie Götz, Jan-Niclas Mumm, Alexander Buchner, Annabel Graser, Jozefina Casuscelli, Christian Stief, Christoph Fürweger, Alexander Muacevic, Michael Staehler | Cancers (Basel) | 2022
Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
Wang B, Dong Y, Yu X, Li F, Wang J, Chen H, Niu Z, Song Y, Yuan Z, Tao Z | Front Oncol | 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
Ryuno Y, Abe T, Iino M, Saito S, Aoshika T, Oota T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Radiat Oncol | 2022
